Virus-like particles as immunogens R Noad, P Roy Trends in microbiology 11 (9), 438-444, 2003 | 783 | 2003 |
Viral infection switches non-plasmacytoid dendritic cells into high interferon producers SS Diebold, M Montoya, H Unger, L Alexopoulou, P Roy, LE Haswell, ... Nature 424 (6946), 324-328, 2003 | 760 | 2003 |
Sputnik V COVID-19 vaccine candidate appears safe and effective I Jones, P Roy The Lancet 397 (10275), 642-643, 2021 | 446 | 2021 |
Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system E Mortola, P Roy FEBS letters 576 (1-2), 174-178, 2004 | 337 | 2004 |
Synthesis of bluetongue virus (BTV) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTV TJ French, P Roy Journal of virology 64 (4), 1530-1536, 1990 | 278 | 1990 |
Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts M Boyce, CCP Celma, P Roy Journal of virology 82 (17), 8339-8348, 2008 | 239 | 2008 |
Bluetongue virus proteins P Roy Journal of General Virology 73 (12), 3051-3064, 1992 | 237 | 1992 |
Family reoviridae PPC Mertens Virus taxonomy. Seventh report of the international committee on taxonomy of …, 2000 | 234 | 2000 |
Crystal structure of SIV matrix antigen and implications for virus assembly Z Rao, AS Belyaev, E Fry, P Roy, IM Jones, DI Stuart Nature 378 (6558), 743-747, 1995 | 232 | 1995 |
Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins TJ French, JJ Marshall, P Roy Journal of virology 64 (12), 5695-5700, 1990 | 232 | 1990 |
Virus‑like particles as a vaccine delivery system: Myths and facts P Roy, R Noad Human vaccines 4 (1), 5-12, 2008 | 217 | 2008 |
Expression and functional characterization of bluetongue virus VP2 protein: role in cell entry SS Hassan, PL Roy Journal of virology 73 (12), 9832-9842, 1999 | 211 | 1999 |
The crystal structure of bluetongue virus VP7 J Grimes, AK Basak, P Roy, D Stuart Nature 373 (6510), 167-170, 1995 | 202 | 1995 |
Bluetongue virus genetics and genome structure P Roy Virus research 13 (3), 179-206, 1989 | 199 | 1989 |
Orbiviruses and their replication. P Roy Fields virology, 1709-1734, 1996 | 196 | 1996 |
Recombinant virus vaccine for bluetongue disease in sheep P Roy, T Urakawa, AA Van Dijk, BJ Erasmus Journal of virology 64 (5), 1998-2003, 1990 | 193 | 1990 |
Development of baculovirus triple and quadruple expression vectors: co-expression of three or four bluetongue virus proteins and the synthesis of bluetongue virus-like … AS Belyaev, P Roy Nucleic acids research 21 (5), 1219-1223, 1993 | 190 | 1993 |
Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection P Roy, DHL Bishop, H LeBlois, BJ Erasmus Vaccine 12 (9), 805-811, 1994 | 187 | 1994 |
The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus release AR Beaton, J Rodriguez, YK Reddy, P Roy Proceedings of the National Academy of Sciences 99 (20), 13154-13159, 2002 | 175 | 2002 |
Release of bluetongue virus-like particles from insect cells is mediated by BTV nonstructural protein NS3/NS3A AD Hyatt, Y Zhao, P Roy Virology 193 (2), 592-603, 1993 | 175 | 1993 |